Evidence map›Paper›PMID 34590921›Full record

ArticleThe Journal of international medical research2021

miR-301-3p directly regulates

Shasha Liu, Yang Zhao, Huan Liu, Xing Zhao, Xingbin Shen

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of international medical research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Perspective and Therapeutic Potential of the Noncoding RNA-Connexin Axis.International journal of molecular sciences · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Shasha LiuDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Hebei, 067000, China.
Yang ZhaoDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Hebei, 067000, China.
Huan LiuDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Hebei, 067000, China.
Xing ZhaoDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Hebei, 067000, China.
Xingbin ShenDepartment of Pathology, Affiliated Hospital of Chengde Medical University, Hebei, 067000, China.ORCID https://orcid.org/0000-0003-4048-7282
Chengde Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIdentifying novel biomarkers involved in the development of gastric cancer (GC) can provide potential therapeutic strategies and improve clinical prognosis. miR-301-3p and

methodsThe expression levels of miR-301-3p and

results

conclusionThe miR-301-3p-

Indexed as

MicroRNAsStomach NeoplasmsCell ProliferationConnexin 43Gene Expression Regulation, NeoplasticHumansConnexin 43MicroRNAsMIRN301A microRNA, humanCx43developmentdifferentiationGastric cancermiR-301-3pmiRNApatient

Identifiers

PMID34590921
PMCPMC8489753
OpenAlexW3202687293

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.